| Product NDC: | 42192-513 |
| Proprietary Name: | ENTRE-B |
| Non Proprietary Name: | BROMPHENIRAMINE MALEATE, PHENYLEPHRINE HCL |
| Active Ingredient(s): | 6; 10 mg/5mL; mg/5mL & nbsp; BROMPHENIRAMINE MALEATE, PHENYLEPHRINE HCL |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 42192-513 |
| Labeler Name: | ACELLA PHARMACEUTICALS |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20101011 |
| Package NDC: | 42192-513-04 |
| Package Description: | 118 mL in 1 BOTTLE (42192-513-04) |
| NDC Code | 42192-513-04 |
| Proprietary Name | ENTRE-B |
| Package Description | 118 mL in 1 BOTTLE (42192-513-04) |
| Product NDC | 42192-513 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | BROMPHENIRAMINE MALEATE, PHENYLEPHRINE HCL |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20101011 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | ACELLA PHARMACEUTICALS |
| Substance Name | BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 6; 10 |
| Strength Unit | mg/5mL; mg/5mL |
| Pharmaceutical Classes |